Survival Statistics For Prostate Cancer
Survival statistics for prostate cancer are very general estimates and must be interpreted very carefully. Because these statistics are based on the experience of groups of people, they cannot be used to predict a particular persons chances of survival. In general, most men diagnosed with prostate cancer do not die from the disease itself and will die from other causes.
There are many different ways to measure and report cancer survival statistics. Your doctor can explain the statistics for prostate cancer and what they mean to you.
Prostate Cancer Survival Rates: What They Mean
As cancer diagnoses go, prostate cancer is often a less serious one. Prostate cancer is frequently slow-growing and slow to spread. For many men, prostate cancer is less serious than their other medical conditions.
For these reasons, and possibly because of earlier detection of low-grade prostate cancers, prostate cancer has one of the highest survival rates of any type of cancer. WebMD takes a look at prostate cancer survival rates and what they mean to you.
Management Of Urinary Dysfunction
Because the urinary symptoms following radiation therapy are irritative in nature, drugs that improve urinary flow and treat irritative bladder symptoms are commonly prescribed to all men following radiation therapy for at least a few weeks. They are gradually withdrawn as symptoms improve.In cases of persistent urinary incontinence, surgical procedures, including a sling that relieves pressure buildup in the abdomen or artificial sphincters provide long lasting results.
You May Like: New Chapter Supercritical Prostate 5lx
Survival By Disease Recurrence
If a man develops an elevated PSA level after cancer surgery, then the disease is viewed as recurrent.
The number of lymph nodes at the time of prostatectomy can influence the risk of recurrence. One study suggests the removal of a large number of nodes is associated with an improvement in odds of recurrence, but this doesnât appear to impact overall survival.
But disease recurrence doesnât always influence survival times. If a recurrence does occur, the 15-year survival rate at the time of diagnosis may be as high as 94% in those with low-risk recurrence.
The main factors influencing survival rates are:
- The Gleason score
- The PSA doubling time
- Whether the recurrence occurred within three years or after three years
A recurrence that occurs within three years reduces survival rates by anywhere from 15 to 20%and even more, if the doubling time is short.
In the past, the life expectancy of men with metastatic prostate cancer was 2-3 years. But with advancements in medicine and care, the life expectancy of men with metastatic prostate cancer has increased to about 5-6 years.
The 5-year survival rate of metastatic prostate cancer is 28%, which is much lower than local and regional prostate cancers. This refers to the percentage of people diagnosed with a particular cancer who can expect to live for at least 5 years after diagnosis.
Can People Recover From Metastatic Prostate Cancer
Recovery depends on the aggressiveness and location of the cancer spread. Local spread and nonaggressive types have a better outlook. Researchers are developing new therapies more quickly than ever before. It is worthwhile for people to check with their doctor about treatment options and participation in clinical trials.
You May Like: What Fruit Is Good For Prostate Cancer
What Are Next Steps
Bone metastasis have a profound effect on the long-term outlook for prostate cancer. But its important to remember that the numbers are only statistics.
The good news is that life expectancy for advanced prostate cancer continues to increase. New treatments and therapies offer both longer life and better quality of life. Speak to your doctor about your treatment options and long-term outlook.
Everyones cancer experience is different. You may find support through sharing your treatment plan with friends and family. Or you can turn to local community groups or online forums like Male Care for advice and reassurance.
Statistical Methods To Build Biochemical Recurrence Prediction Models
Available preoperative parameters for multivariate analysis were age, clinical TNM stage, Gleason score from biopsy specimen , PSA and acid phosphatase level. Available postoperative variables were organ confinement, focal extraprostatic extension, extensive extraprostatic extension, lymph node involvement, seminal vesicle invasion, surgical margin status and Gleason score from surgical specimen.
Actuarial analysis was performed comparing freedom from biochemical recurrence after radical retropubic prostatectomy . Patients were censored if they were lost to followup or there was no recurrence. Event time distributions for the time to recurrence end point were estimated with the Kaplan-Meier method and compared using the log rank statistic or the proportional hazards regression model. The simultaneous effect of two or more factors was studied using the multivariate proportional hazards model. Covariates and interactions marginally significant in univariate analyses were entered into the multivariate regression model and insignificant effects were removed in a stepwise fashion. The first model was developed using preoperative variables only and the second model using all available variables.
Recommended Reading: Va Asbestos And Prostate Cancer
What Is The Life Expectancy After Prostate Removal
. Besides, can you live a long life after prostate cancer?
You can live a long time with prostate cancer, maybe even decades. If you catch and treat it early, you might even be able to cure it.
Secondly, can you still get hard if you have your prostate removed? When you have a radical prostatectomy, you have surgery to remove your prostate gland. These nerves, blood vessels, and muscles may be weakened when you have surgery for your prostate cancer. However, you may find that you cannot have an erection even a year or more after surgery.
Moreover, what happens if you have your prostate removed?
Side effects of prostate surgery. The major possible side effects of radical prostatectomy are urinary incontinence and erectile dysfunction . Men with stress incontinence might leak urine when they cough, laugh, sneeze, or exercise.
Are you ever cured of prostate cancer?
The short answer is yes, prostate cancer can be cured, when detected and treated early. The vast majority of prostate cancer cases are discovered in the early stages, making the tumors more likely to respond to treatment. Treatment doesnt always have to mean surgery or chemotherapy, either.
Also Check: Prostate Cancer And Leg Pain
Keeping Health Insurance And Copies Of Your Medical Records
Even after treatment, its very important to keep health insurance. Tests and doctor visits cost a lot, and although no one wants to think of their cancer coming back, this could happen.
At some point after your cancer treatment, you might find yourself seeing a new doctor who doesnt know your medical history. Its important to keep copies of your medical records to give your new doctor the details of your diagnosis and treatment.
Recommended Reading: Elevated Prostate Specific Antigen Icd 10
Stage 4 Prostate Cancer: Survival Rates Treatment And Support
Prostate cancer is in stage 4 when the cancer spreads beyond the lymph nodes and into other areas of the body. While the vast majority of prostate cancer cases are caught before this happens, when the cancer is treatable, stage 4 is far more difficult to treat. Therefore, the survival rate among men with stage 4 prostate cancer is much lower.
There are two types of stage 4 prostate cancer: 4A and 4B, according to the American Cancer Society. The type assigned to a persons diagnosis is based on whether the cancer has spread and to what degree, and the value assigned to two additional factors called the Grade Group and the prostate-specific antigen . The Grade Group is a measure of how likely the cancer is to spread quickly, and the PSA is a measure of a protein in the blood produced by cells in the prostate.
With stage 4A, the tumor has already spread into the lymph nodes and may be spreading into tissues adjacent to the prostate, but has not spread to other areas of the body. The Grade Group can be of any value, as can the PSA.
With stage 4B, the tumor may have spread into the lymph nodes, may be spreading into nearby tissues and has spread to other areas of the body like the bones, certain organs and distant lymph nodes. The Grade Group and PSA can be of any value.
Recurrence Of Prostate Cancer Life Expectancy
According to the table above, when the prostate cancer recurrence rate is low, then life expectancy generally is 10 years or higher. When calculating life expectancy to a prostate expectancy too.
Meanwhile, if the recurrence rate is high, then most probably the tumor will involve the adjacent areas. And often the recurrence seems to occur after 6-8 years of radical prostatectomy.
In cases of metastastasis, it is difficult to assess the period of relapse. This is actually considered as very high risk zone.
Sometimes, the actual cause is not the prostate cancer, but some other associated problems. Thats why, it is highly recommended regular annual check-ups not only to tackle prostate cancer, but also a scheduled check-up to detect its recurrence and related problems too.
You May Like: Can You Remove A Prostate
What Does The Biopsy Say About Your Prostate Cancer
When abnormal results are discovered from prostate cancer screen tests, the Digital Rectal Exam and PSA Blood Test, a biopsy may be recommended. The Gleason Score is the rating system assigned to the results of the biopsy. This type of biopsy is normally performed using transrectal ultrasound guidance. The ultrasound allows the physician to take distributed samples from the prostate. Typically twelve separate samples are taken. A pathologist will then examine the tissue samples under a microscope to determine whether or not the prostate contains cancerous tissue. A grade is assigned to the tissue samples. The two most common grades are added together to create the Gleason Score.
Prostate Cancer is classified by the Gleason Score. A Prostate Cancer Gleason Score or Grade helps to determine how aggressively the prostate cancer is likely to behave. The score will help classify the cancer by grading how quickly it it is likely to grow. The score also is a an indicator in how likely it is to spread outside of the prostate gland.
What Is Stage 4 Prostate Cancer
The fourth stage of prostate cancerdefines a tumor that has progressed to other regions of the body, such as the lymph nodes, lungs, liver, bones, or bladder. The 5-year survival rate for these tumors is 29 percent.
Keep in mind that each case is unique, and figures like these are merely suggestions. As advances in prostate cancer treatment become more common, your odds of surviving this disease improve.
In general, prostate cancer has a very good survival rate one of the greatest of any cancer type. Because prostate cancer is frequently a slow-moving disease, the majority of men diagnosed with it will die from an unrelated reason.
Stage 4 prostate cancer means the cancer has spread to lymph nodes or to other parts of the body. It is further divided into two substages:
- Prostate Cancer Stage 4A Stage 4A: The cancer has spread to nearby lymph nodes but may or may not have spread to nearby tissues.
- Prostate Cancer Stage 4B Stage 4B: The cancer has spread to another area of the body, such as the bones or distant lymph nodes.
Also Check: What Is The Best Over The Counter Prostate Medicine
What Is A Patients Life Expectancy After A Stage 4 Prostate Cancer Diagnosis
A Stage 4 prostate cancer diagnosis is reserved for those whose cancer has progressed outside the prostate to other organs. Usually the cancer is no longer responding to hormonal therapy at this point. There are a variety of medications available for patients with this diagnosis to help extend their length and quality of life. Dr. Howard Tay discusses these medications and life expectancy with Stage 4 prostate cancer in this video.
To learn more about Stage 4 prostate cancer watch Treatment Options for Stage IV Prostate Cancer with Dr. Howard Tay.
Video Transcripts
Donât Miss: Is There A Cure To Prostate Cancer
Death From Other Causes
The mean age at metastatic prostate cancer diagnosis in the study was roughly 71 years. Most of the cohort was White and had a diagnosis of stage M1b metastatic prostate cancer , which means the cancer had spread to the bones.
Among men in the cohort, the rates of death from septicemia, suicide, accidents, COPD, and cerebrovascular diseases were significantly increased compared with the general US male population, the team observes.
Thus, the study authors were concerned with not only with death from metastatic prostate cancer, but death from other causes.
That concern is rooted in the established fact that there is now improved survival among patients with prostate cancer in the US, including among men with advanced disease. âPatients tend to live long enough after a prostate cancer diagnosis for noncancer-related comorbidities to be associated with their overall survival,â they write.
The editorialists agree: prostate cancer âhas a high long-term survival rate compared with almost all other cancer types and signals the need for greater holistic care for patients.â
As noted above, cardiovascular diseases were the most common cause of non-prostate cancer-related deaths in the new study.
As in the management of other cancers, there is concern among clinicians and researchers about the cardiotoxic effects of prostate cancer treatments.
The study had no specific funding. The study authors and editorialists have disclosed no relevant financial relationships.
You May Like: Side Effects Of Prostate Cancer
Castrate Refractory Prostate Cancer: A Wider Range Of Options
In this section, we explain the treatments available at Birmingham Prostate Clinic for patients once their disease becomes resistant to hormone treatment, called castrate refractory prostate cancer. Two types of treatments are needed to:
- Control the cancer and preventing further spread of cancer
- Control or prevent the symptoms caused by the spread of prostate cancer to the bones
Donât Miss: How Do They Treat An Enlarged Prostate
Managing Symptoms Of Advanced Prostate Cancer
Symptoms can often be improved by treating the cancer, but there are other ways to control symptoms. Tell your doctor or specialist nurse if you have new symptoms or symptoms get worse.
You may see a doctor or nurse who specialises in pain and symptom control. They are sometimes called palliative care specialists.
Some people find complementary therapies such as relaxation, gentle massage, or aromatherapy help you feel better and more in control.
Recommended Reading: When To Stop Active Surveillance For Prostate Cancer
Prostate Cancer And Its Risk Factors
Prostate cancer is a malignant growth of a walnut-shape male organ called the prostate.
Prostate cancer is currently the 2nd most common neoplasm worldwide the disease is diagnosed in over 1,200,000 men every year. The statistic says that 1 in 9 American males will develop prostate cancer at some point in their lives.
We also have some good news more than 98% of prostate cancer patients will survive at least 10 years.
Prostate cancer risk factors:
- Family history of prostate/breast/ovarian cancer, especially at a young age
| The tumor has spread to other organs, or lymph nodes | Please find informations below |
As we can see, the survival and life expectancy of a patient with stages T1-T3 are not that different from the general population. Majority of prostate cancer patients will die of another reason than the neoplasm itself.
Stage 4 prostate cancer life expectancy depends on the presence of metastases fragments of cancer that have spread to other organs of the body, outside of the pelvis.
Metastatic prostate cancer life expectancy.
- Cancer with metastases is automatically a Stage 4 cancer.
- In this case, stage four prostate cancer survival rate equals 31% it means that only 1/3 of patients with metastases will survive another five years.
Watchful Waiting Or Active Surveillance/active Monitoring
Asymptomatic patients of advanced age or with concomitant illness may warrantconsideration of careful observation without immediate active treatment. Watch and wait, observation, expectant management, and active surveillance/active monitoring are terms indicating a strategy that does not employ immediate therapy with curative intent.
Watchful waiting and active surveillance/active monitoring are the most commonly used terms, and the literature does not always clearly distinguish them, making the interpretation of results difficult. The general concept of watchful waiting is patient follow-up with the application of palliative care as needed to alleviate symptoms of tumor progression. There is no planned attempt at curative therapy at any point in follow-up. For example, transurethral resection of the prostate or hormonal therapy may be used to alleviate tumor-related urethral obstruction should there be local tumor growth hormonal therapy or bone radiation might be used to alleviate pain from metastases. Radical prostatectomy has been compared with watchful waiting or active surveillance/active monitoring in men with early-stage disease .
- Regular patient visits.
- Transrectal ultrasound .
- Transrectal needle biopsies .
Patient selection, testing intervals, and specific tests, as well as criteria for intervention, are arbitrary and not established in controlled trials.
Recommended Reading: Nccn Prostate Cancer Guidelines 2022
What Are The Treatment Options For Prostate Cancer
Treatment for prostate cancer is determined based on the size of the tumor and extent of metastasis and may include the following:
Hormone therapy
Hormone treatment deprives the body of the male hormones needed for prostate cancer growth. Orchiectomy or luteinizing hormone-releasing hormone analogs are used alone or in conjunction with an anti-androgen.
Newer hormonal drugs that decrease androgen production and block androgen receptor signaling have been approved by the FDA for the treatment of metastatic prostate cancer following chemotherapy, and they are being studied for early usage in the disease.
Abiraterone
Abiraterone is an oral targeted medication that inhibits androgen synthesis not only in the testes but also in the adrenal glands and the tumor itself. When used with prednisone, abiraterone has been demonstrated to improve quality of life and decrease pain progression in patients with hormone-refractory prostate cancer .
Although this drug is normally well tolerated, adverse effects such as tiredness, elevated blood pressure, and electrolyte or liver problems are possible, and patients must be checked on a regular basis.
Enzalutamide
Enzalutamide interferes with molecular processes that enable prostate cancer growth by targeting various stages in the androgen-receptor-signaling cascade. Furthermore, the medicine does not cause the typical adverse effects of chemotherapy, such as nausea and hair loss.
Chemotherapy